
[New Latin prostata, from Greek prostatēs (adēn), prostate (gland), from proïstanai, to set before : pro-, in front; see pro-2 + histanai, to set, place.]
prostatic pros·tat'ic (prŏ-stăt'ĭk) adj.The prostate gland surrounds the urinary passage at the exit of the male bladder. The gland is very small in babies and grows at the time of puberty in response to testosterone secreted by the testicles. The function of the prostate is to secrete fluid which together with secretions from the seminal vesicles makes up most of the volume of the seminal fluid. The functions of seminal fluid are incompletely understood and more than a hundred compounds have been isolated from it. The gland has given its name to the group of substances known as prostaglandins, first identified at this site, but now known to be present throughout the body; prostaglandins in the seminal fluid may cause contractions of the female genital tract, facilitating transport of sperm through the uterus to the Fallopian tubes. The fluid also helps with the nutrition of sperm and defence against infection. The ejaculate forms a clot which sticks to the mucus of the cervix, enabling the passage of sperm into the mucus, through which they can travel to enter the uterus. An enzyme called prostatic specific antigen (PSA) then liquefies the sperm clot and the seminal fluid subsequently seeps out of the vagina. PSA is produced by the lining cells of prostate ducts and a small amount can be detected circulating in the blood. Any condition that increases prostate cells, such as benign enlargement of the prostate, or cancer, or any condition which causes leakiness of the cells such as prostatitis, results in increased levels of PSA in the blood. Very high levels of PSA usually indicate cancer, but moderately raised levels may indicate a whole variety of prostate disorders. There is worldwide research on the merits of PSA estimation as a screening test for prostate cancer but because increased levels may occur in a number of prostate disorders it can never be a perfect test.
Most men remain unaware of their prostate until late middle age when enlargement interferes with urination by constricting the urethra and reducing urine flow. This is often associated with the need to rise at night and pass urine more frequently. For more minor symptoms, there is effective drug treatment. When the symptoms become sufficiently disabling the usual treatment is an operation. The current lifetime chance of requiring a prostate operation is about one in ten. Prostate cancer is very common in elderly men and is a significant cause of premature death, but the paradox is that many more men have prostate cancer than die of it. Benign enlargement of the prostate and in some cases, cancer, can be treated by operations to remove part, or in cancer cases, the whole of the prostate. Many men fear these operations will result in impotence. In most cases of benign enlargement of the prostate there is no danger of impotence. Removal of part or all of the prostate does however result in a lack of external ejaculation because the junctions between the genital and urinary tracts lie within the prostate. In operations to remove the gland completely, it is possible for the nerves to the penis to be damaged, since they run close to the prostate. For many men with prostate cancer, total removal by operation is not feasible and the mainstay of treatment is to give hormones. Both the normal and the cancerous prostate grow in response to testosterone and the strategy of hormone treatments is to deprive the cancer of male hormone. This can be done in a number of different ways, both by blocking production of testosterone and by blocking its action. Hormone treatments are not curative but they may remain effective for many years.
— Tim Hargreave
Bibliography
See urogenital system. See also ejaculation; semen; sex hormones.
| KEY TERMS Androgen—A male sex hormone. Benign—Non-cancerous. Benign prostatic hyperplasia (BPH)—A non-cancerous condition of the prostate that causes growth of the prostate tissue, thus enlarging the prostate and obstructing urination. Prostate-specific antigen (PSA)—A blood test that helps in the early diagnosis of prostate cancer. Testosterone—A male sex hormone produced mainly by the testicles. Urethra—The tube that carries urine from the bladder out of the body and in men carries semen during ejaculation. |
| prostate-specific antigen, prostasin, prostanoid | |
| prosthetic group, prostin, protachykinin β precursor |
Pertaining to or emanating from the prostate.
A gland in men that surrounds the neck of the bladder and the urethra and produces a secretion that liquefies coagulated semen.
| Prostate | |
|---|---|
![]() |
|
| Male Anatomy | |
| Prostate with seminal vesicles and seminal ducts, viewed from in front and above. | |
| Latin | prostata |
| Gray's | subject #263 1251 |
| Artery | internal pudendal artery, inferior vesical artery, and middle rectal artery |
| Vein | prostatic venous plexus, pudendal plexus, vesicle plexus, internal iliac vein |
| Nerve | inferior hypogastric plexus |
| Lymph | external iliac lymph nodes, internal iliac lymph nodes, sacral lymph nodes |
| Precursor | Endodermic evaginations of the urethra |
| MeSH | Prostate |
| Dorlands/Elsevier | Prostate |
The prostate (from Greek προστάτης - prostates, literally "one who stands before", "protector", "guardian"[1]) is a compound tubuloalveolar exocrine gland of the male reproductive system in most mammals.[2][3]
In 2002, female paraurethral glands, or Skene's glands, were officially renamed the female prostate by the Federative International Committee on Anatomical Terminology.[4]
The prostate differs considerably among species anatomically, chemically, and physiologically.
|
Contents
|
The function of the prostate is to secrete a slightly acidic fluid, milky or white in appearance,[5] that usually constitutes 20–30% of the volume of the semen along with spermatozoa and seminal vesicle fluid[6]. Semen is made alkaline overall with the secretions from the other contributing glands, including, at least, the seminal vesicle fluid . The alkalinity of semen helps neutralize the acidity of the vaginal tract, prolonging the lifespan of sperm. The alkalinization of semen is primarily accomplished through secretion from the seminal vesicles.[7] The prostatic fluid is expelled in the first ejaculate fractions, together with most of the spermatozoa. In comparison with the few spermatozoa expelled together with mainly seminal vesicular fluid, those expelled in prostatic fluid have better motility, longer survival and better protection of the genetic material (DNA).
The prostate also contains some smooth muscles that help expel semen during ejaculation.
Prostatic secretions vary among species. They are generally composed of simple sugars and are often slightly acidic.
In human prostatic secretions, the protein content is less than 1% and includes proteolytic enzymes, prostatic acid phosphatase, beta-microseminoprotein, and prostate-specific antigen. The secretions also contain zinc with a concentration 500–1,000 times the concentration in blood.
To work properly, the prostate needs male hormones (testosterones), which are responsible for male sex characteristics.
The main male hormone is testosterone, which is produced mainly by the testicles. Some male hormones are produced in small amounts by the adrenal glands. However, it is dihydrotestosterone that regulates the prostate.
The prostatic part of the urethra develops from the pelvic (middle) part of the urogenital sinus (endodermal origin). Endodermal outgrowths arise from the prostatic part of the urethra and grow into the surrounding mesenchyme. The glandular epithelium of the prostate differentiates from these endodermal cells, and the associated mesenchyme differentiates into the dense stroma and the smooth muscle of the prostate.[8] The prostate glands represent the modified wall of the proximal portion of the male urethra and arises by the 9th week of embryonic life in the development of the reproductive system. Condensation of mesenchyme, urethra and Wolffian ducts gives rise to the adult prostate gland, a composite organ made up of several glandular and non-glandular components tightly fused.
The Skene's gland, also known as the paraurethral gland, found in females, is homologous to the prostate gland in males. However, anatomically, the uterus is in the same position as the prostate gland. In 2002 the Skene's gland was officially renamed to female prostate by the Federative International Committee on Anatomical Terminology.[9]
The female prostate, like the male prostate, secretes PSA and levels of this antigen rise in the presence of carcinoma of the gland. The gland also expels fluid, like the male prostate, during orgasm.[10]
A healthy human prostate is classically said to be slightly larger than a walnut. The mean weight of the "normal" prostate in adult males is about 11 grams, usually ranging between 7 and 16 grams.[11] It surrounds the urethra just below the urinary bladder and can be felt during a rectal exam. It is the only exocrine organ located in the midline in humans and similar animals.
The secretory epithelium is mainly pseudostratified, comprising tall columnar cells and basal cells which are supported by a fibroelastic stroma containing randomly orientated smooth muscle bundles. The epithelium is highly variable and areas of low cuboidal or squamous epithelium are also present, with transitional epithelium in the distal regions of the longer ducts.[12] Within the prostate, the urethra coming from the bladder is called the prostatic urethra and merges with the two ejaculatory ducts.
The prostate does not have a capsule, rather an integral fibromuscular band surrounds it.[13] It is sheathed in the muscles of the pelvic floor, which contract during the ejaculatory process.
The prostate can be divided in two ways: by zone, or by lobe.[14]
The "zone" classification is more often used in pathology. The idea of "zones" was first proposed by McNeal in 1968. McNeal found that the relatively homogeneous cut surface of an adult prostate in no way resembled "lobes" and thus led to the description of "zones."[15]
The prostate gland has four distinct glandular regions, two of which arise from different segments of the prostatic urethra:
| Name | Fraction of gland | Description |
| Peripheral zone (PZ) | Up to 70% in young men | The sub-capsular portion of the posterior aspect of the prostate gland that surrounds the distal urethra. It is from this portion of the gland that ~70–80% of prostatic cancers originate.[16][17] |
| Central zone (CZ) | Approximately 25% normally | This zone surrounds the ejaculatory ducts. The central zone accounts for roughly 2.5% of prostate cancers although these cancers tend to be more aggressive and more likely to invade the seminal vesicles.[18] |
| Transition zone (TZ) | 5% at puberty | ~10–20% of prostate cancers originate in this zone. The transition zone surrounds the proximal urethra and is the region of the prostate gland that grows throughout life and is responsible for the disease of benign prostatic enlargement. (2)[16][17] |
| Anterior fibro-muscular zone (or stroma) | Approximately 5% | This zone is usually devoid of glandular components, and composed only, as its name suggests, of muscle and fibrous tissue. |
The "lobe" classification is more often used in anatomy.
| Anterior lobe (or isthmus) | roughly corresponds to part of transitional zone |
| Posterior lobe | roughly corresponds to peripheral zone |
| Lateral lobes | spans all zones |
| Median lobe (or middle lobe) | roughly corresponds to part of central zone |
Prostatitis is inflammation of the prostate gland. There are primarily four different forms of prostatitis, each with different causes and outcomes. Two relatively uncommon forms, acute prostatitis and chronic bacterial prostatitis, are treated with antibiotics (category I and II, respectively). Chronic non-bacterial prostatitis or male chronic pelvic pain syndrome (category III), which comprises about 95% of prostatitis diagnoses, is treated by a large variety of modalities including alpha blockers, phytotherapy, physical therapy, psychotherapy, antihistamines, anxiolytics, nerve modulators, surgery,[19] and more.[20] More recently, a combination of trigger point and psychological therapy has proved effective for category III prostatitis as well.[21] Category IV prostatitis, relatively uncommon in the general population, is a type of leukocytosis.
Benign prostatic hyperplasia (BPH) occurs in older men;[22] the prostate often enlarges to the point where urination becomes difficult. Symptoms include needing to urinate often (frequency) or taking a while to get started (hesitancy). If the prostate grows too large, it may constrict the urethra and impede the flow of urine, making urination difficult and painful and, in extreme cases, completely impossible.
BPH can be treated with medication, a minimally invasive procedure or, in extreme cases, surgery that removes the prostate. Minimally invasive procedures include transurethral needle ablation of the prostate (TUNA) and transurethral microwave thermotherapy (TUMT).[23] These outpatient procedures may be followed by the insertion of a temporary prostatic stent, to allow normal voluntary urination, without exacerbating irritative symptoms.[24]
The surgery most often used in such cases is called transurethral resection of the prostate (TURP or TUR). In TURP, an instrument is inserted through the urethra to remove prostate tissue that is pressing against the upper part of the urethra and restricting the flow of urine. TURP results in the removal of mostly transitional zone tissue in a patient with BPH. Older men often have corpora amylacea[25] (amyloid), dense accumulations of calcified proteinaceous material, in the ducts of their prostates. The corpora amylacea may obstruct the lumens of the prostatic ducts, and may underlie some cases of BPH.
Urinary frequency due to bladder spasm, common in older men, may be confused with prostatic hyperplasia. Statistical observations suggest that a diet low in fat and red meat and high in protein and vegetables, as well as regular alcohol consumption, could protect against BPH.[26]
Prostate cancer is one of the most common cancers affecting older men in developed countries and a significant cause of death for elderly men (estimated by some specialists at 3%). Despite this, the American Cancer Society's position regarding early detection is "Research has not yet proven that the potential benefits of testing outweigh the harms of testing and treatment. The American Cancer Society believes that men should not be tested without learning about what we know and don’t know about the risks and possible benefits of testing and treatment. Starting at age 50, (45 if African American or brother or father suffered from condition before age 65) talk to your doctor about the pros and cons of testing so you can decide if testing is the right choice for you."[27]
If checks are performed, they can be in the form of a physical rectal exam, measurement of prostate specific antigen (PSA) level in the blood, or checking for the presence of the protein Engrailed-2 (EN2) in the urine.
Co-researchers Hardev Pandha and Richard Morgan published their findings regarding checking for EN2 in urine in the 1 March 2011 issue of the journal Clinical Cancer Research.[28] A laboratory test currently identifies EN2 in urine, and a home test kit is envisioned similar to a home pregnancy test strip. According to Morgan, "We are preparing several large studies in the UK and in the US and although the EN2 test is not yet available, several companies have expressed interest in taking it forward." [29]
During male ejaculation, sperm is transmitted from the ductus deferens into the male urethra via the ejaculatory ducts, which lie within the prostate gland.
In 1983, the Journal of the American Medical Association revealed a connection between vasectomy and an increased risk of prostate cancer. Reported studies of 48,000 and 29,000 men who had vasectomies showed 66 percent and 56 percent higher rates of prostate cancer, respectively. The risk increased with age and the number of years since the vasectomy was performed.
However, in March of the same year, the National Institute of Child Health and Human Development held a conference cosponsored by the National Cancer Institute and others to review the available data and information on the link between prostate cancer and vasectomies. It was determined that an association between the two was very weak at best, and even if having a vasectomy increased one's risk, the risk was relatively small.
In 1997, the NCI held a conference with the prostate cancer Progressive Review Group (a committee of scientists, medical personnel, and others). Their final report, published in 1998 stated that evidence that vasectomies help to develop prostate cancer was weak at best.[30]
A surgeon can unclog a blocked prostate by inserting an artificial 'tube' called a stent. Stents can be temporary or permanent. They are inserted into the urethra. This is mostly done on an outpatient basis under local or spinal anesthesia and takes about 30 minutes.
|
| Book: Prostate | |
| Wikipedia books are collections of articles that can be downloaded or ordered in print. | |
The text of this article was originally taken from NIH Publication No. 02-4806, a public domain resource.[31]
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)
idioms:
Français (French)
n. - prostate
idioms:
Deutsch (German)
n. - Prostata, Vorsteherdrüse
idioms:
Ελληνική (Greek)
n. - (ανατ.) προστάτης
adj. - (ανατ.) του προστάτη
idioms:
idioms:
Português (Portuguese)
n. - próstata (f)
adj. - prostático
idioms:
idioms:
Español (Spanish)
n. - próstata
idioms:
Svenska (Swedish)
n. - prostata
adj. - prostata-
中文(简体)(Chinese (Simplified))
前列腺
idioms:
中文(繁體)(Chinese (Traditional))
n. - 前列腺
idioms:
idioms:
العربيه (Arabic)
(الاسم) غدة المثانه (صفه) ما يخص هذه الغدة
If you are unable to view some languages clearly, click here.